A Phase 2 Trial of MLN8237 in Adult Participants With Acute Myelogenous Leukemia and High-Grade Myelodysplastic Syndrome
Clinical trial NCT00830518 · COMPLETED
Trial details
- NCT number
- NCT00830518
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-10
- Primary completion
- 2010-02-02
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.